Rachel A. Rabin

Rachel A. Rabin

McGill University

H-index: 16

North America-Canada

About Rachel A. Rabin

Rachel A. Rabin, With an exceptional h-index of 16 and a recent h-index of 14 (since 2020), a distinguished researcher at McGill University, specializes in the field of Psychiatric disorders, Addictions, Cognition, Treatment.

His recent articles reflect a diverse array of research interests and contributions to the field:

Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis

Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

Neuromelanin levels in individuals with substance use disorders: A systematic review and meta-analysis

Tobacco Use among Individuals with Cannabis Use

325. Cannabis Cravings Predict Compensatory Increases in Cigarette Use in Schizophrenia: Findings From Cannabis Abstinence Studies

Brain health in ethnically minority youth at risk for psychosis

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?

Rachel A. Rabin Information

University

Position

___

Citations(all)

1037

Citations(since 2020)

567

Cited By

682

hIndex(all)

16

hIndex(since 2020)

14

i10Index(all)

26

i10Index(since 2020)

19

Email

University Profile Page

Google Scholar

Rachel A. Rabin Skills & Research Interests

Psychiatric disorders

Addictions

Cognition

Treatment

Top articles of Rachel A. Rabin

Title

Journal

Author(s)

Publication Date

Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis

Schizophrenia Bulletin

Cassandra MJ Wannan

Barnaby Nelson

Jean Addington

Kelly Allott

Alan Anticevic

...

2024/5/1

Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

The American Journal of Drug and Alcohol Abuse

Samantha Johnstone

Maryam Sorkhou

Molly Zhang

Sarah S Dermody

Rachel A Rabin

...

2024/1/2

Neuromelanin levels in individuals with substance use disorders: A systematic review and meta-analysis

Jessica Ahrens

Farida Zaher

Rachel A Rabin

Clifford M Cassidy

Lena Palaniyappan

2024/6/1

Tobacco Use among Individuals with Cannabis Use

Marijuana and Madness

Rachel A Rabin

Erin A McClure

Tony P George

2023/6/1

325. Cannabis Cravings Predict Compensatory Increases in Cigarette Use in Schizophrenia: Findings From Cannabis Abstinence Studies

Biological Psychiatry

Yunyi Zhang

Samantha Johnstone

Maryam Sorkhou

Sarah Dermody

Rachel Rabin

...

2023/5/1

Brain health in ethnically minority youth at risk for psychosis

Neuropsychopharmacology

Rachel A Rabin

Lena Palaniyappan

2023/11

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

EClinicalMedicine

Mathilde Argote

Guillaume Sescousse

Jérôme Brunelin

Grégoire Baudin

Michael Patrick Schaub

...

2023/10/1

Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?

The American Journal on Addictions

Zac JS Yeap

Justine Marsault

Tony P George

Romina Mizrahi

Rachel A Rabin

2023/7

Emotion recognition in individuals with cocaine use disorder: the role of abstinence length and the social brain network

Psychopharmacology

Rachel A Rabin

Muhammad A Parvaz

Nelly Alia-Klein

Rita Z Goldstein

2022/4

Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies

Muhammad A Parvaz

Rachel A Rabin

Faith Adams

Rita Z Goldstein

2022/3/1

Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia

Schizophrenia

Karolina Kozak Bidzinski

Darby JE Lowe

Marcos Sanches

Maryam Sorkhou

Isabelle Boileau

...

2022/2/24

Neurocognitive moderation of repetitive transcranial magnetic stimulation (rTMS) effects on cannabis use in schizophrenia: a preliminary analysis

Schizophrenia

Samantha Johnstone

Darby JE Lowe

Karolina Kozak-Bidzinski

Marcos Sanches

David J Castle

...

2022/11/17

Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study

The American Journal on Addictions

Maryam Sorkhou

Rachel A Rabin

Jennifer S Rabin

Stefan Kloiber

Roger S McIntyre

...

2022/9

Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia

Drug and Alcohol Dependence

Samantha Johnstone

Maryam Sorkhou

Rachel A Rabin

Tony P George

2022/5/1

A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness

Karolina Kozak

Philip H. Smith

Darby JE Lowe

Andrea H Weinberger

Ziva D Cooper

...

2021/9/3

Commentary on Walsh et al.(2020): Tobacco and cannabis co‐use—considerations for treatment.

Addiction

Rachel A Rabin

2020/10/1

Common and gender-specific associations with cocaine use on gray matter volume: Data from the ENIGMA addiction working group

Human brain mapping

Rachel A Rabin

Scott Mackey

Muhammad A Parvaz

Janna Cousijn

Chiang-Shan Li

...

2020

Treatment implications associated with cannabis and tobacco co-use

Erin A McClure

Rachel A Rabin

Dustin C Lee

Chandni Hindocha

2020/12

See List of Professors in Rachel A. Rabin University(McGill University)